Literature DB >> 9409733

Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids.

S An1, T Bleu, W Huang, O G Hallmark, S R Coughlin, E J Goetzl.   

Abstract

The structural similarity of lysosphingolipids to lysophosphatidic acid (LPA) prompted a sequence-based search for lysosphingolipid receptors using cDNA sequence of the Edg2 human LPA receptor. Two closely related G protein-coupled receptors, rat H218 and human Edg3, are highly similar to Edg2. When overexpressed in Jurkat cells, H218 and Edg3 activated serum response element-driven transcriptional reporter gene in response to sphingosine 1-phosphate (S1P), dihydro-S1P and sphingosylphosphorylcholine, but not to LPA. H218 and Edg3 expressed in Xenopus oocytes conferred responsiveness to S1P and dihydro-S1P in agonist-triggered 45Ca2+ efflux. Therefore, H218 and Edg3 are functional receptors for S1P and perhaps other closely related lysosphingolipids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409733     DOI: 10.1016/s0014-5793(97)01301-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  54 in total

1.  Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid.

Authors:  J A Weiner; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 3.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 4.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

5.  Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.

Authors:  Makoto Taniguchi; Kazuyuki Kitatani; Tadakazu Kondo; Mayumi Hashimoto-Nishimura; Satoshi Asano; Akira Hayashi; Susumu Mitsutake; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Junzo Kigawa; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.

Authors:  Jun Xu; Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

Review 7.  Sphingosine-1-phosphate receptor subtype 2 signaling in endothelial senescence-associated functional impairments and inflammation.

Authors:  Jiawei Zhao; Dante Garcia; Allison Gartung; Menq-Jer Lee
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

8.  Intracellular calcium mobilization and phospholipid degradation in sphingosylphosphorylcholine-stimulated human airway epithelial cells.

Authors:  S Orlati; A M Porcelli; S Hrelia; A Lorenzini; M Rugolo
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

10.  Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells.

Authors:  F Okajima; K Sato; H Tomura; A Kuwabara; H Nochi; K Tamoto; Y Kondo; Y Tokumitsu; M Ui
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.